Ó£»¨ÊÓƵ

Skip to main content

Table 4 Analytical table of the factors associated with full COVID-19 vaccination

From: Factors associated with full COVID-19 vaccination among persons living with diabetes mellitus in Uganda–A cross-sectional study

Covariates

Full COVID-19 Vaccination (≥ 2 doses or 1 dose for the J&J)

Unadjusted estimates

uPR (95% CI)

Adjusted estimates

aPR (95% CI)

No n (%)

Yes n (%)

Gender

ÌýÌýÌýÌý

Female

102 (40)

153 (60)

1

1

Male

43 (50.59)

42 (49.41)

0.82 (0.65–1.04)

0.85 (0.67–1.08)

Age

ÌýÌýÌýÌý

20–29

10 (66.67)

5 (33.3)

1

1

30–39

19 (47.5)

21 (52.5)

1.58 (0.73–3.42)

1.6 (0.76–3.4)

40–49

33 (41.77)

46 (58.23)

1.75 (0.83–3.66)

1.58 (0.78–3.26)

50–59

46 (45.1)

56 (54.9)

1.65 (0.79–3.45)

1.72 (0.83–3.53)

60+

37 (35.58)

67 (64.42)

1.93 (0.93–4.01)

1.82 (0.89–3.76)

Educational level

ÌýÌýÌýÌý

No education

11 (33.3)

22 (66.7)

1

Ìý

Primary

79 (44.4)

99 (55.6)

0.83 (0.63–1.09)

Ìý

Secondary

37 (40.2)

55 (59.8)

0.89 (0.67–1.2)

Ìý

Tertiary/ vocational

13 (52)

12 (48)

0.72 (0.45–1.16)

Ìý

University

5 (41.7)

7 (58.3)

0.88 (0.51–1.49)

Ìý

Marital status

ÌýÌýÌýÌý

Married

75 (46)

88 (54)

1

Ìý

Never married

6 (42.9)

8 (57.1)

1.06 (0.66–1.7)

Ìý

Divorced/widowed

64 (39.3)

99 (60.7)

1.13 (0.93–1.36)

Ìý

Religion

ÌýÌýÌýÌý

Adventist

3 (50)

3 (50)

1

Ìý

Catholic

50 (43.9)

64 (56.1)

1.12 (0.49–2.54)

Ìý

Muslim

44 (50)

44 (50)

1 (0.44–2.29)

Ìý

Pentecostal

15 (36.6)

26 (63.4)

1.27 (0.55–2.92)

Ìý

Protestant

32 (36)

57 (64)

1.28 (0.57–2.89)

Ìý

Others

1 (50)

1 (50)

1 (0.44–4.96)

Ìý

Duration with DM (years)

ÌýÌýÌýÌý

0–4

68 (54)

58 (46)

1

Ìý

5–9

25 (37.9)

41 (62.1)

1.35 (1.03–1.76)

Ìý

10–14

18 (32.1)

38 (67.9)

1.47 (1.13–1.91)

Ìý

15–19

5 (25)

15 (75)

1.63 (1.19–2.24)

Ìý

20+

11 (42.3)

15 (57.7)

1.25 (0.86–1.83)

Ìý

Comorbidity with DM

ÌýÌýÌýÌý

No

70 (48.95)

73 (51.05)

1

1

Yes

75 (38.07)

122 (61.93)

1.21 (0.99–1.47)

1.26 (1.06–1.53)

COVID-19 diagnosis of close family/peers

ÌýÌýÌýÌý

No

110 (45.64)

131 (54.36)

1

Ìý

Yes

35 (35.35)

64 (64.65)

1.19 (0.99–1.43)

Ìý

Previous diagnosis of self

ÌýÌýÌýÌý

No

133 (42.2)

182 (57.8)

1

Ìý

Yes

12 (48)

13 (52)

0.9 (0.61–1.33)

Ìý

Perceived susceptibility to COVID-19 infection

ÌýÌýÌýÌý

Weak perceived susceptibility

24 (47.06)

27 (52.94)

1

Ìý

Strongly perceived susceptibility

121 (41.87)

168 (58.13)

1.09 (0.83–1.44)

Ìý

Perceived severity of COVID-19 infection

ÌýÌýÌýÌý

Weak perceived severity

13 (35.14)

24 (64.86)

1

Ìý

Strongly perceived severity

132 (43.56)

171 (56.44)

0.87 (0.67–1.12)

Ìý

Perceived benefit of full vaccination

ÌýÌýÌýÌý

Weak perceived benefit

38 (66.7)

19 (33.3)

1

1

Strong perceived benefit

107 (37.8)

176 (62.2)

1.87 (1.28–2.72)

1.76 (1.23–2.53)

Perceived barrier to full vaccination

ÌýÌýÌýÌý

Weak perceived barrier

34 (27.87)

88 (72.13)

1

1

Strong perceived barrier

111 (50.92)

107 (49.08)

0.68 (0.57–0.81)

0.71 (0.6–0.84)

Ever seen promotional messages on media

ÌýÌýÌýÌý

No

3 (50)

3 (50)

1

Ìý

Yes

142 (42.5)

192 (57.5)

1.15 (0.51–2.58)

Ìý

Advice from a health provider

ÌýÌýÌýÌý

No

26 (68.42)

12 (31.58)

1

1

Yes

119 (39.4)

183 (60.6)

1.92 (1.19–3.09)

1.91 (1.20–3.02)

  1. Statistical results in bold – Statistically significant at the significance level of 0.05